Validation of Multi-epitope Peptides Encapsulated in PLGA Nanoparticles Against Influenza A Virus
Authors:
- 21 June 2023
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 40 (8) , 1999-2025
Abstract
Influenza is a highly contagious respiratory disease which poses a serious threat to public health globally, causing severe diseases in 3-5 million humansKeywords
This publication has 88 references indexed in Scilit:
- An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challengeVirology Journal, 2013
- Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeuticsProceedings of the National Academy of Sciences, 2012
- Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approachExpert Review of Vaccines, 2012
- Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriersInternational Journal of Nanomedicine, 2011
- CpG DNA as a vaccine adjuvantExpert Review of Vaccines, 2011
- Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentVirology Journal, 2010
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypesProceedings of the National Academy of Sciences, 2010
- Baseline Mechanical Characterization of J774 MacrophagesBiophysical Journal, 2009
- Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in HumansJournal of Virology, 2008
- Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skinClinical and Experimental Immunology, 2006